Next Article in Journal
Reply to Leong et al. Comment on “Hosseini et al. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2134”
Previous Article in Journal
Neurodevelopmental Outcomes in Preterm Infants Receiving a Multicomponent vs. a Soybean-Based Lipid Emulsion: 24 Month Follow-Up of a Randomized Controlled Trial
 
 
Reply published on 23 December 2022, see Nutrients 2023, 15(1), 60.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Comment on Hosseini et al. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2134

Cochrane-South Africa, South African Medical Research Council, Parow 7503, South Africa
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(1), 59; https://doi.org/10.3390/nu15010059
Submission received: 25 August 2022 / Accepted: 7 December 2022 / Published: 23 December 2022
(This article belongs to the Section Micronutrients and Human Health)
Medicines have been re-purposed as therapeutics for COVID-19 and it is with great interest that we read the publication entitled, “Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis” [1]. The authors aimed to systematically review the literature to evaluate vitamin D as a therapeutic agent and reported that Vitamin D was associated with a reduced risk of ICU admission and mortality. We note several limitations to the review that were detected when appraising it to inform clinical practice. Notably, data from randomized controlled trials (RCTs) and non-randomized studies of intervention were meta-analyzed with totals of the results of both provided. In addition, there are several concerns regarding an RCT [2] included in the review authored by one of the review authors (BH), however, no declaration regarding potential conflicts of interest was noted. Increasingly, it is recognized that leads of RCTs may have specific views on the intervention under investigation and therefore should declare their interests and potentially recuse themselves from decisions about eligibility, appraisal, analysis, and interpretation of results where their own study is involved [3]. The RCT in question was appraised as low risk of bias across all domains (appraisers BH and HAE). Furthermore, the status of the study is “Terminated” on the clinicaltrials.gov registry (NCT04483635), and “A premature discontinuation was recommended by the Data Safety Monitoring Board and agreed upon by the principal investigator, because the significantly lower recruitment than planned, in the context of mass vaccination of the target population)”-no published study results for the 34 study participants are available for review and we are uncertain how the data was assessed. Authors of an earlier systematic review [4] concluded that evidence for vitamin D supplementation to treat COVID-19 was insufficient and very uncertain and raised concerns regarding substantial clinical and methodological heterogeneity amongst studies (varying supplementation strategies, formulations, vitamin D status of participants, and reported outcomes). This is reflected in decisions by international guidelines groups such as NICE [5], the Pan American Health Organization [6], and Australian National COVID-19 Clinical Evidence Taskforce [6], recommending against the use of vitamin D to treat COVID-19 except as part of a clinical trial. Overall, we suggest that the current knowledge base remains uncertain pending the publication of high-quality RCTs. We, therefore, await the results of ongoing registered studies [7], to inform the evidence base and guide more definitive clinical practice.

Author Contributions

Conceptualization, T.D.L.; formal analysis, T.D.L., N.B., D.M. and T.K.; investigation, T.D.L. and N.B.; data curation, T.D.L.; writing—original draft preparation, T.D.L.; writing—review and editing, T.K., N.B. and D.M.; project administration, T.D.L. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

T.D.L. and T.K. support, oversee and conduct rapid evidence syntheses to inform national guidelines on COVID-19. N.B. and D.M. disclose no financial and personal relationships with other people or organizations that could inappropriately influence their work.

References

  1. Hosseini, B.; El Abd, A.; Ducharme, F.M. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2134. [Google Scholar] [CrossRef] [PubMed]
  2. Hosseini, B.; Tremblay, C.; Longo, C.; Golchi, S.; White, J.; Quach, C. Prevention of COVID-19 with Oral Vitamin D Supplemental Therapy in Essential Healthcare Teams (PROTECT): Ancillary Study of a Randomized Controlled Trial. Available online: https://clinicaltrials.gov/ct2/show/NCT04483635 (accessed on 10 August 2022).
  3. Cochrane Conflict of Interest Policy for Cochrane Library Content: Section 5.4: Other Non-Financial (Relevant) Interests, March 2020. Available online: https://training.cochrane.org/online-learning/editorial-policies/coi-policy/coi-policy-cochrane-library (accessed on 23 August 2022).
  4. Stroehlein, J.K.; Wallqvist, J.; Iannizzi, C.; Mikolajewska, A.; Metzendorf, M.I.; Benstoem, C.; Meybohm, P.; Becker, M.; Skoetz, N.; Stegemann, M.; et al. Vitamin D supplementation for the treatment of COVID-19: A living systematic review. Cochrane Database Syst. Rev. 2021, 5, CD015043. [Google Scholar] [CrossRef] [PubMed]
  5. The National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: Managing COVID-19 Version 27.0. 2022. Available online: https://www.nice.org.uk/guidance/NG187 (accessed on 10 August 2022).
  6. CIHR. COVID-19 Recommendations. Evidence Prime. 2022. Available online: https://covid19.recmap.org/recommendation/9d34f327-682a-45c0-a19d-d12f347c1b1d. (accessed on 13 August 2022).
  7. The COVID-19 Living NMA Initiative: Living Map. Paris: CRESS UMR-153. Available online: https://covid-nma.com/ (accessed on 22 August 2022).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Leong, T.D.; Blose, N.; Mabetha, D.; Kredo, T. Comment on Hosseini et al. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2134. Nutrients 2023, 15, 59. https://doi.org/10.3390/nu15010059

AMA Style

Leong TD, Blose N, Mabetha D, Kredo T. Comment on Hosseini et al. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2134. Nutrients. 2023; 15(1):59. https://doi.org/10.3390/nu15010059

Chicago/Turabian Style

Leong, Trudy D., Ntombifuthi Blose, Denny Mabetha, and Tamara Kredo. 2023. "Comment on Hosseini et al. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2134" Nutrients 15, no. 1: 59. https://doi.org/10.3390/nu15010059

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop